Digital Health Wire
FEBRUARY 8, 2023
It’s also one of the only companies that checks every box on CVS’ list: strong leadership; integrated tech platform; agnostic to different geographies and payors; demonstrable capability to improve outcomes; clear path toward profitability. As for synergies, CVS sees 500 million of them, or at least five that can unlock $500M in value.
Digital Health Global
AUGUST 1, 2023
This year, Omada for Diabetes and its Diabetes+Hypertension programs earned renewed NCQA accreditation through 2026––the longest accreditation possible. In 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance ’s (NCQA) Population Health Program (PHP) Accreditation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
DECEMBER 14, 2023
USCDI Version 3 : Adopts the United States Core Data for Interoperability (USCDI) Version 3 (v3) as the new baseline standard within the ONC Health IT Certification Program (Certification Program) as of January 1, 2026. Developers of certified health IT will also have the ability to move to USCDI v3 sooner.
Healthcare IT Today
AUGUST 26, 2022
billion by 2026. PenRad provides software, and leadership towards standardization. Notably, the mammography market is expected to increase by more than 20% in the next several years, while the lung cancer diagnostics market is expected to reach $3.4 PenRad is at the front lines of care as demand surges.
Lloyd Price
FEBRUARY 22, 2024
Billion by 2026. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Remote patient monitoring: Continuous data collection for proactive intervention and improved outcomes.
Lloyd Price
NOVEMBER 25, 2023
Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. These rollups will reshape the competitive landscape, driving innovation, improving patient care, and influencing the future of healthcare delivery.
Lloyd Price
NOVEMBER 27, 2023
The MSK market is expected to reach $462 billion by 2026, driven by factors such as the aging population, the increasing prevalence of chronic musculoskeletal conditions, and the rising cost of traditional MSK care. Despite the decline in valuation multiples, there is still a strong appetite for investment in digital MSK companies.
Expert insights. Personalized for you.
98 
Let's personalize your content